Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV ...

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

In the face of a fear of loss of funds for ending the HIV/AIDS epidemic, activists in New Jersey walked to raise money.

In a first-ever milestone, Africa’s initial HIV cure trial has yielded historic findings: 20% of patients have remained off ...

Exclusive: World Health Organisation says shortage of most commonly used Aids drug caused by withdrawal of US foreign aid ...

On April 22, the CDC allegedly informed Emory University in Atlanta that its large HIV self-testing program was being ...

After counsel withdrew for some of the plaintiffs in a huge consolidated legal battle between Gilead Sciences and patients ...

NEW YORK (Reuters) -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the ...

Dozens of trials on HIV ground to a halt in February after US President Donald Trump abruptly pulled crucial funding.